Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Brochures & Literature

 

 

View Channel

 

Conferences | Events

Researchers put the Paradigm of Endless Endpoint Assays in Biased Agonism Studies to Question

publication date: May 20, 2016
 | 
author/source: BMG LABTECH

BMG LABTECH’s Readers are Used to Measure Binding Kinetics Over Minutes

/BMG labtech Single reading events of a signaling molecule at a given time should no longer be considered as the only insightful indicator to predict the usefulness of a new drug candidate. In fact, the authors of a new study claim that it is necessary to explore the kinetic context of the binding event instead.

So far, it was very hard to run time-based kinetics in Time-Resolved Fluorescence (TRF) due to the requirements of the assay kits. Researchers now measured binding events in a kinetic over minutes, using BMG LABTECH´s microplate readers and detecting Time-Resolved FRET signals and real-time live cell based biosensors by BRET.

A monitored receptor-ligand binding event (biased agonism) is not sufficient to predict the usefulness of a new drug candidate. This is claimed by Australian researchers of the Monash University in collaboration with the universities of Nottingham (UK) and Columbia (NY, USA). The recently published Nature paper “The role of kinetic context in apparent biased agonism at GPCRs”, Herenbrink et al., 2016, show that it is necessary to explore the kinetic context of the binding event resulting in Dissociation constant (KD), kon and koff values instead of a single time point. To prove this thesis, the dopamine D2 receptor, a common GPCR, was studied in combination with selected agonists for multiple signaling pathways.

The bias profile of a series of agonists for the dopamine D2 receptor changed dramatically in case the ligand-binding kinetics as well as the kinetics associated with different cell signaling processes were considered. In some cases, it even led to reversals in the direction of bias. This should be taken into account by every researcher who is designing and interpreting biased agonism studies.

BMG LABTECH’s microplate reader PHERAstar® FS was used to detect fluorescent ligand-binding assays of Time-Resolved FRET signals. Kinetic acquisitions at intervals of 20 seconds were recorded for up to 90 minutes using the standard HTRF® instrument settings. Agonist-based receptor stimulation was further monitored using BRET-based biosensors. BMG LABTECH´s PHERAstar® FS and LUMIstar® Omega equipped with BRET-specific optics were used to capture the signals. Both readers enable the detection of end point signalling assays with HTRF with ease, but they can also detect the most sensitive and fastest real time cell based analysis using live cell biosensors.


more about BMG labtech


more news from BMG labtech


 

 

 


If you have not logged into the website then please enter your details below.



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month...

Our Top 10 most popular articles this month

 

Today's Picks...

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners